Talk to our Consultant - Head And Neck Squamous Cell Carcinoma Market Grow at CAGR of 9.5% By 2027

Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market Research Report: Forecast (2022-27)

By Diagnosis (Blood Tests, Biopsy, Biomarker Testing, Nasopharyngolaryngoscopy, Imaging (X-ray, CT/PET Scan, MRI)), By Treatment (Surgery, Radiation Therapy, Chemotherapy, (Docetaxel, Cisplatin, 5-Flu... ... el, Cisplatin, 5-Flurouracil, Methotrexate, Others (Bleomycin, etc.)), Immunotherapy (Keytruda (Pembrolizumab), Opdivo (Nivolumab)), Targeted Therapy (Cetuximab), Others (Combination Therapy, etc.)), By End-User (Hospitals, Clinics, Specialty Cancer Centers), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Country (The US, Canada, Mexico, Brazil, the UK, Germany, France, Italy, Spain, South Africa, GCC, China, Japan, India, Australia, South East Asia) Read more

Healthcare
Jul 2022
Pages 195
Report Format: PDF, Excel, PPT

Market Definition

HNSCC (Head & Neck Squamous Cell Carcinoma) is cancer that develops in mucous membranes of the mouth, throat, & nose and showcases severe symptoms like:

Abnormal patches or open sores in the mouth & throat
Unusual pain & bleeding in the mouth
Difficulties in breathing, etc.

The Oral Cavity, Paranasal Sinuses, Nasal Cavity, Oropharynx, Larynx, Hypopharynx, & Nasopharynx are various locations where HNSCC can occur. In case of late detection or non-treatment, it can also spread across other parts like the lungs or lymph nodes, making the situation fatal. Hence, with the criticality of addressing such health conditions, several governments & prominent biopharma companies are actively participating in various research & development activities to bring innovations in therapeutics and cater to the unmet patient needs worldwide.

Market Insights

The Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market is projected to grow at around 9.5% CAGR during the forecast period, i.e., 2022-27. The growth of the market is driven primarily by the mounting prevalence of HNSCC, i.e., augmenting the demand for diagnosis & treatment and, in turn, instigating governments of different countries to increase their respective healthcare expenditures for drug developments to cater to the high unmet requirements of patients worldwide.

Report Coverage	Details
Study Period	Historical Data: 2017-20
	Base Year: 2021
	Forecast Period: 2022-27
CAGR	9.5%
Regions Covered	North America: The US, Canada, Mexico
	South America: Brazil, Rest of Latin America
	Europe: Germany, The UK, France, Italy, Spain, Rest of Europe
	Middle East & Africa: GCC, South Africa, Rest of Middle East and Africa
	Asia-Pacific: China, Japan, India, Australia, South East Asia, Rest of Asia-Pacific
Key Companies Profiled	AbbVie Inc., AstraZeneca PLC, Amgen Inc., Bayer AG, Bristol Myers Squibb, DFG Oncology, Dr. Reddy’s Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Jiangsu Hengrui, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Sanofi S.A., Others
Unit Denominations	USD Million/Billion

As several countries are laying out favorable policies for the research & development and clinical trials of novel drugs, the global market is observing the active participation of the leading players. The primary causes of HNSCC include smoking, alcohol consumption, HPV (Human Papillomavirus) infection for oropharyngeal cancer, & EBV (Epstein-Barr Virus) infection for nasopharyngeal cancer.

Governments worldwide are encouraging several research institutions to indulge immensely in developing effective chemotherapy & immunotherapy drugs for the treatment of HNSCC patients. Moreover, they are also spreading awareness among people about the ill effects of smoking & alcohol consumption and the availability of effective diagnosis & treatment for HNSCC.

Additionally, they are massively investing in the oncology sector, pharmaceutical giants, cancer associations, and other organizations for the research & development associated with HNSCC therapeutics, thereby generating lucrative opportunities for the various companies participating in the Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market.

Moreover, as treatments like chemotherapy are being adopted extensively by patients across different corners of the world, the demand for drugs like Docetaxel, Cisplatin, & Bleomycin, among others, is rising swiftly and, in turn, instigating the leading biopharma companies to increase their production & distribution capacities in order to cater to the high unmet patient needs

Introduction
1. Research Process
2. Assumption
3. Market Segmentation
4. Market Definition
Executive Summary
Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market Trends & Insights
Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market Regulation & Policy, By Country
Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market Hotspot and Opportunities
Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
    1. Blood Tests
    2. Biopsy
    3. Biomarker Testing
    4. Nasopharyngolaryngoscopy
    5. Imaging (X-ray, CT/PET Scan, MRI)
  2. By Treatment
    1. Surgery
    2. Radiation Therapy
    3. Chemotherapy
      1. Docetaxel
      2. Cisplatin
      3. 5-Flurouracil
      4. Methotrexate
      5. Others (Bleomycin, etc.)
    4. Immunotherapy
      1. Keytruda (Pembrolizumab)
      2. Opdivo (Nivolumab)
    5. Targeted Therapy
      1. Cetuximab
    6. Others (Combination Therapy, etc.)
  3. By End-User
    1. Hospitals
    2. Clinics
    3. Specialty Cancer Centers
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Competition Characteristics
    2. Revenue Shares
    3. Competitor Placement in MarkNtel Advisor’s Quadrant
North America Head and Neck Squamous Cell Carcinoma (HNSCC) Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. The US
    2. Canada
    3. Mexico
South America Head and Neck Squamous Cell Carcinoma (HNSCC) Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. Brazil
    2. Rest of Latin America
Europe Head and Neck Squamous Cell Carcinoma (HNSCC) Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
Middle East & Africa Head and Neck Squamous Cell Carcinoma (HNSCC) Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. South Africa
    2. GCC
    3. Rest of Middle East & Africa
Asia-Pacific Head and Neck Squamous Cell Carcinoma (HNSCC) Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. China
    2. Japan
    3. India
    4. Australia
    5. South East Asia
    6. Rest of Asia-Pacific
Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market Key Strategic Imperatives for Success and Growth
Competitive Outlook
1. Competition Matrix
  1. By Application Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Target by Applications
  5. Research & Development
  6. Strategic Alliances
  7. Strategic Initiatives
2. Company Profiles (Business Description, By Application Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. AbbVie Inc.
  2. AstraZeneca PLC
  3. Amgen Inc.
  4. Bayer AG
  5. Bristol Myers Squibb
  6. DFG Oncology
  7. Dr. Reddy’s Laboratories
  8. Eli Lilly and Company
  9. F. Hoffmann-La Roche AG
  10. Jiangsu Hengrui
  11. Merck & Co., Inc.
  12. Novartis International AG
  13. Pfizer Inc.
  14. Sanofi S.A.
  15. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying